Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 19 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2018$150,000
-86.6%
254,330
-11.5%
0.00%
-100.0%
Q2 2018$1,122,000
+246.3%
287,300
+166.0%
0.00%
Q1 2018$324,000
+25.6%
108,000
+44.4%
0.00%
Q4 2017$258,000
+44.1%
74,800
+90.8%
0.00%
Q3 2017$179,000
-20.4%
39,200
-18.6%
0.00%
Q1 2017$225,00048,1510.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 699,500$3,113,0000.02%
DRW Securities, LLC 20,000$89,0000.01%
SG Americas Securities, LLC 13,500$60,0000.00%
Winch Advisory Services, LLC 300$1,0000.00%
Renaissance Technologies 287,300$1,122,0000.00%
DIMENSIONAL FUND ADVISORS LP 54,850$244,0000.00%
BANK OF AMERICA CORP /DE/ 270$1,0000.00%
WELLS FARGO & COMPANY/MN 4,500$20,0000.00%
NORTHERN TRUST CORP 12,480$56,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 38,714$172,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders